Detalhe da pesquisa
1.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Ann Intern Med
; 176(5): 658-666, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37068272
2.
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.
J Infect Dis
; 228(2): 133-142, 2023 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36661240
3.
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.
Clin Infect Dis
; 77(7): 941-949, 2023 10 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37279602
4.
A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.
Clin Infect Dis
; 66(12): 1928-1936, 2018 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29697768
5.
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.
JAMA Netw Open
; 6(4): e2310039, 2023 04 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37099295